Sodium Cellulose Phosphate
Title: Sodium Cellulose Phosphate
CAS Registry Number: 9038-41-9
Additional Names: SCP
Trademarks: Calcibind (Mission Pharmacal); Calcisorb (3M Pharma)
Literature References: Non-absorbable ion exchange resin with high affinity for calcium ions. Prepn: G. P. Touey, US 2759924 (1956 to Eastman Kodak). Use in treatment of hypercalcemia: C. Y. C. Pak et al., J. Clin. Endocrinol. Metab. 28, 1828 (1968). Mechanism of action: C. Y. C. Pak, J. Clin. Pharmacol. 13, 15 (1973). Clinical pharmacology: idem, ibid. 19, 451 (1979). Use in treatment of calcium urolithiasis: U. Backman et al., J. Urol. 123, 9 (1980); C. Y. C. Pak, Invest. Urol. 19, 187 (1981).
Properties: Powder. Insol in water.
Use: As ion exchange resin.
Therap-Cat: Treatment of calcium urolithiasis.

Others monographs:
DeoxyuridinePipecolic AcidCodeine N-Oxide5-Bromosalicylic Acid Acetate
XylitolNarcotolineChlorthalidoneHaloxazolam
Bismuth GermanateCloxotestosteroneDifemerineBromoacetic Acid
Chromium Dioxide1,2-Di-p-tolylethaneTriphenylphosphineTriflumuron
©2016 DrugLead US FDA&EMEA